Botox HOME
Botox Facts .ca
Your Online Resource Centre for Botox Information.
Skin Care Guide Canada
Botox Facts About Us Dermatology Glossary and Images Skin Care Network Botox Facts.ca Site Map

 

 

Botox Facts. CA - References

  • Barrientos N, Chana P. Efficacy and safety of botulinum toxin type A (BOTOX) in the prophylactic treatment of migraine [abstract]. Presented at the American Headache Society 44th Annual Scientific Meeting 2002; 21–23 June: Seattle, Washington.

  • Biglan AW, Burnstine RA, Rogers GL, et al. Management of strabismus with botulinum A toxin. Ophthalmology 1989;96:935-943.

  • Binder WJ, Brin MF, Blitzer A, et al. Botulinum toxin type A (BOTOX) for treatment of migraine headaches: An open-label study. Otolaryngol Head Neck Surg 2000;123:669-676.

  • Blumenfeld A. Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders. Headache 2003;43:853-860.

  • Borodic GE, Ferrante R. Effects of repeated botulinum toxin injections on orbicularis oculi muscle. J Clin Neuroophthalmol 1992;12:121-127.

  • Brashear A, Gordon MF, Elovic E, et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med 2002;347:395-400.

  • Calderon-Gonzalez R, Calderon-Sepulveda RF, Rincon-Reyes M, Garcia Ramirez J, Mino-Arango E. Botulinum toxin A in management of cerebral palsy. Pediatr Neurol 1994;10:284-288.

  • Campanati A, Penna L, Guzzo T, et al. Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: Results of an open-label study. Clin Ther 2003;25:298-308.

  • Carruthers A, Carruthers J. Botulinum toxin type A: History and current cosmetic use in the upper face. Semin Cutan Med Surg 2001;20:71-84.

  • Carruthers J, Carruthers A. BOTOX use in the mid and lower face and neck. Semin Cutan Med Surg 2001;20:85-92.

  • Carruthers J, Stubbs HA. Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid entropion. Can J Neurol Sci 1987;14:42-45.

  • Carruthers J, Lowe JN, Menter MA, et al. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A in patients with glabellar lines. Plast Reconstr Surg 2003;15:1089-1098.

  • Carruthers JA, Lowe NJ, Menter MA, et al. A multicentre, double-blind, randomized, placebo-controlled study of efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002;46:840-849.

  • Carruthers JD. Ophthalmologic use of botulinum A exotoxin. Can J Ophthalmol 1985;20:135-141.

  • De Paiva A, Meunier FA, Molgo J, Aoki KR, Dolly JO. Functional repair of motor endplates after botulinum neurotoxin typ A poisoning: Biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci USA 1999;96:3200-3205.

  • Defazio G, Abbruzzese G, Girlanda P, et al. Botulinum toxin A treatment for primary hemifacial spasm: A 10-year multicenter study. Arch Neurol 2002;59:418-420.

  • Dutton J. Acute and chronic effects of botulinum toxin in the management of blepharospasm. In: Therapy with botulinum toxin. Jankovic J, Hallat M, eds. New York: Marcel Dekker, Inc.; 1994.

  • Dutton JJ, Buckley EG. Botulinum toxin in the management of blepharospasm. Arch Neurol 1986;43:380-382.

  • Fagien S, Brandt FS. Primary and adjunctive use of botulinum toxin type A (Botox) in facial aesthetic surgery : Beyond the glabella. Clin Plast Surg 2001;28 :127-148.

  • Flanders M, Tischler A, Wise J, et al. Injection of type A botulinum toxin into extraocular muscles for correction of strabismus. Can J Ophthalmol 1987;22:212-217.

  • Flynn TC, Carruthers JA, Carruthers JA. Botulinum-A toxin treatment of the lower eyelid improves infraorbital rhytides and widens the eye. Dermatol Surg 2001;27:703-708.

  • Foster L, Clapp L, Erickson M, Jabbari B. Botulinum toxin A and chronic low back pain: A randomized double blind study. Neurology 2001;56:1290-1293.

  • Freund BJ, Schwartz M. A focal dystonia model for subsets of chronic tension headache [abstract]. Cephalalgia 2000;20:433.

  • Göbel H, Lindner V, Krack PK, et al. Treatment of chronic tension-type headache with botulinum toxin [abstract]. Cephalalgia 1999;19:455.

  • Heckmann M, Teichmann B, Pause BM, Plewig G. Amelioration of body odor after intracutaneous axillary injection of botulinum toxin A. Arch Dermatol 2003;139:57-59.

  • Hsiung GY, Das SK, Ranawaya R, Lafontaine AL, Suchowersky O. Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period. Mov Disord 2002;17:1288-1293.

  • Huang W, Rogachefsky AS, Foster JA. Brow lift with botulinum toxin. Dermatol Surg 2000;26:55-60.

  • Jankovic J, Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology 1990;40:277-280.

  • Jankovic J, Schwartz KS. Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia. Neurology 1993;43:834-836.

  • Koman LA, Mooney JF, Mulvaney T, Roberts S, Smith BP. Further evaluation of botulinum A toxin (BOTOX) in the management of cerebral palsy. Dev Med Child Neurol 1993;69:29-30.

  • Koman LA, Mooney JF III, Smith BP, Goodman A, Mulvaney T. Management of spasticity in cerebral palsy with botulinum A toxin: Report of a preliminary, randomized, double-blind trial. J Pediatr Orthop 1994;14:299-303.

  • Koman LA, Mooney JF III, Smith BP, Walker F, Leon JM. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: A randomized, double-blind, placebo-controlled trial. J Pediatr Orthop 2000;20:108-115.

  • Lennerstrand G, Nordbo OA, Tian S, et al. Treatment of strabismus and nystagmus with botulinum toxin type A: An evaluation of effects and complications. Acta Ophthalmol Scand 1998;76:27-37.

  • Lowe PL, Cerdan-Sanz S, Lowe NJ. Botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis: Efficacy and duration with repeated treatments. Dermatol Surg 2003;29:545-548.

  • Magoon EH. Chemodenervation of strabismic children. A 2- to 5-year follow-up study compared with shorter follow-up. Ophthalmology 1989;96:931-934.

  • Mathew NT, Kallasam J, Kaupp A, Meadors L. "Disease modification" in chronic migraine with botulinum toxin type A: Long-term experience [abstract]. Presented at the American Headache Society 44th Annual Scientific Meeting 2002; 21–23 June: Seattle, Washington.

  • Mauskop A. Long-term use of botulinum toxine type A (BOTOX) in the treatment of episodic and chronic migraine headaches. Presented at the American Headache Society 44th Annual Scientific Meeting 2002; 21–23 June: Seattle, Washington.

  • Metaxiotis D, Siebel A, Doederlein L. Repeated botulinum toxin A injections in the treatment of spastic equinus foot. Clin Orthop 2002;394:177-185.

  • Naumann M, Lowe NJ. Botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis: A randomized, parallel group, double blind, placebo-controlled trial. BMJ 2001;323:596-599.

  • Naumann M, Lowe NJ, Kumar CR, Hamm H. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: A prospective study. Arch Dermatol 2003;139:731-736.

  • Park MY, Ahn KY, Jung DS. Application of botulinum toxin A for treatment of facial contouring in the lower face. Dermatol Surg 2003;29:477-483.

  • Petitto VB, Buckley EG. Use of botulinum toxin in strabismus after retinal detachment surgery. Ophthalmology 1991;98:509-513.

  • Poungvarin N, Devahastin V, Chaisevikul R, Prayoonwiwat N, Viriyavejakul A. Botulinum A toxin treatment for blepharospasm and Meige syndrome: Report of 100 patients. J Med Assoc Thai 1997;80:1-8.

  • Relja M. Treatment of tension-type headache by local injection of botulinum toxin. Eur J Neurol 1997;4(Suppl 2):S71-S73.

  • Schulte-Mattler WJ, Wieser T, Zierz S. Treatment of tension-type headache with botulinum toxin: A pilot study. Eur J Med Res 1999;4:183-186.

  • Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 1980;87:1044-1049.

  • Scott AB, Kennedy RA, Stubbs HA. Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol 1985;103:347-350.

  • Scott AB, Magoon EH, McNeer KW, Stager DR. Botulinum treatment of childhood strabismus. Ophthalmology 1990;97:1434-1438.

  • Silberstein S, Mathew N, Saper J, et al. Botulinum toxin type A as a migraine preventive treatment. Headache 2000;40:445-450.

  • Smuts JA, Baker MK, Smuts HM, et al. Prophylactic treatment of chronic tension-type headache using botulinum toxin type A. Eur J Neurol 1999;6(Suppl 4):S99-S102.

  • Tan NC, Chan LL, Tan EK. Hemifacial spasm and involuntary facial movements. QJM 2002;95:493-500.

  • Tsoy EA, Buckley EG, Dutton JJ. Treatment of blepharospasm with botulinum toxin. Am J Ophthalmol. 1985;99:176-179.

  • Velickovic M, Benabou R, Brin MF. Cervical dystonia: Pathophysiology and treatment options. Drugs 2001;61:1921-1943.

  • Wang A, Jankovic J. Hemifacial spasm: Clinical findings and treatment. Muscle Nerve 1998;21:1740-1747.

  • Wheeler A, Goelkusian A, Gretz S. Randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory unilateral, cervicothoracic, paraspinal, myofascial pain syndrome. Spine 1998;23:1662-1667.

  • Zwart JA, Bovim G, Sand T, et al. Tension headache: Botulinum toxin paralysis of temporal muscles. Headache 1994;34:458-462.